loadpatents
name:-0.0679771900177
name:-0.0608229637146
name:-0.010718107223511
Houpis; Ioannis Nicolaos Patent Filings

Houpis; Ioannis Nicolaos

Patent Applications and Registrations

Patent applications and USPTO patent grants for Houpis; Ioannis Nicolaos.The latest application filed is for "uracyl spirooxetane nucleosides".

Company Profile
11.13.15
  • Houpis; Ioannis Nicolaos - Antwerp BE
  • Houpis; Ioannis Nicolaos - Beerse N/A BE
  • Houpis; Ioannis Nicolaos - Antwrep N/A BE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Uracyl spirooxetane nucleosides
Grant 10,774,106 - Houpis , et al. Sept
2020-09-15
Uracyl Spirooxetane Nucleosides
App 20200109161 - Houpis; Ioannis Nicolaos ;   et al.
2020-04-09
Process for the preparation of compounds useful as inhibitors of SGLT2
Grant 10,544,135 - Houpis , et al. Ja
2020-01-28
Uracyl spirooxetane nucleosides
Grant 10,544,184 - Houpis , et al. Ja
2020-01-28
Deuterated triazolopyridazine as a kinase modulator
Grant 10,464,939 - Furer , et al. No
2019-11-05
Uracyl Spirooxetane Nucleosides
App 20190241604 - Houpis; Ioannis Nicolaos ;   et al.
2019-08-08
Process For The Preparation Of Compounds Useful As Inhibitors Of Sglt2
App 20190194177 - Houpis; Ioannis Nicolaos ;   et al.
2019-06-27
Uracyl spirooxetane nucleosides
Grant 10,301,347 - Houpis , et al.
2019-05-28
Uracyl Spirooxetane Nucleosides
App 20190092804 - Houpis; Ioannis Nicolaos ;   et al.
2019-03-28
Uracyl Spirooxetane Nucleosides
App 20180327441 - Houpis; Ioannis Nicolaos ;   et al.
2018-11-15
Uracyl spirooxetane nucleosides
Grant 10,040,814 - Houpis , et al. August 7, 2
2018-08-07
Uracyl Spirooxetane Nucleosides
App 20180099990 - Houpis; Ioannis Nicolaos ;   et al.
2018-04-12
Uracyl spirooxetane nucleosides
Grant 9,845,336 - Houpis , et al. December 19, 2
2017-12-19
Uracyl Spirooxetane Nucleosides
App 20170145045 - Houpis; Ioannis Nicolaos ;   et al.
2017-05-25
Uracyl Spirooxetane Nucleosides
App 20170029455 - Houpis; Ioannis Nicolaos ;   et al.
2017-02-02
Benzimidazole-imidazole Derivatives
App 20160340344 - Vandyck; Koen ;   et al.
2016-11-24
Benzimidazole-imidazole derivatives
Grant 9,433,609 - Vandyck , et al. September 6, 2
2016-09-06
Benzimidazole-imidazole derivatives
Grant 9,427,428 - Vandyck , et al. August 30, 2
2016-08-30
Uracyl spirooxetane nucleosides
Grant 9,422,323 - Houpis , et al. August 23, 2
2016-08-23
Processes And Intermediates For Preparing A Medicament
App 20150376193 - PYE; Philip ;   et al.
2015-12-31
Processes and intermediates for preparing a medicament
Grant 9,156,847 - Pye , et al. October 13, 2
2015-10-13
Uracyl Spirooxetane Nucleosides
App 20150141365 - Houpis; Ioannis Nicolaos ;   et al.
2015-05-21
Processes And Intermediates For Preparing A Medicament
App 20140275126 - PYE; Philip ;   et al.
2014-09-18
Benzimidazole-imidazole derivatives
App 20140107172 - Vandyck; Koen ;   et al.
2014-04-17
Benzimidazole-imidazole Derivatives
App 20120219594 - Vandyck; Koen ;   et al.
2012-08-30
Novel Intermediate For Glyt1 Inhibitor
App 20090253918 - Houpis; Ioannis Nicolaos ;   et al.
2009-10-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed